News
NEWS
-
newsCelaid Therapeutics to Participate in the Biotech Showcase 2026 in San Francisco During JPM Week
-
newsCelaid Therapeutics to Present at RESI JPM 2026 (San Francisco, USA)
-
newsSelected as a participating company in LabCentral's “Next Phase Program”
-
newsWinner of the Health and Medical Venture Grand Prize (Drug Discovery & SaMD League)
-
newsJoining the Shonan Health Innovation Conference (SHIC) in Boston
-
R&DCore patents for albumin-free, serum-free HSC expansion method allowed in Japan
-
newsJoining the 2025 AABB/Cord Blood Connect in San Diego
-
financing
Celaid Therapeutics Raises JPY 1.055 Billion (USD 7.2 Million) in the First Close of its Series B Financing
-
HRCareer Opportunities
- 1
- 2